The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
about
Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke.Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis.The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis.A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation.Clinical studies and anti-inflammatory mechanisms of treatments.Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis.Fingolimod-improved axonal and myelin integrity of white matter tracts associated with multiple sclerosis-related functional impairments.What role does multiple sclerosis play in the development of untreatable painful conditions?Fingolimod Protects Against Ischemic White Matter Damage by Modulating Microglia Toward M2 Polarization via STAT3 Pathway.To the Brain and Back: Migratory Paths of Dendritic Cells in Multiple Sclerosis.Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).Emerging Role of Immunity in Cerebral Small Vessel Disease.Approach to Fingolimod-Induced Lymphopenia in Multiple Sclerosis Patients: Do We Have a Roadmap?Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling
P2860
Q37209163-B05C7E60-F58C-4331-A79B-1A6CA7D2F60CQ38622668-03C899F3-4D32-4957-B4A7-36E6B0AA19EAQ39021621-BA6813C6-E71E-4557-BA45-E4BA9AA44FA6Q40047199-4046471E-7DF1-4A03-8DBA-33E03BDE6EDAQ41573128-1359E4E3-07B2-4620-AC47-A393655C302DQ47124754-891C4720-1522-42BE-88EA-43B81A507EBAQ47130362-C5C85F25-658C-48F5-8985-B977DDF266AEQ47188693-77013644-D0AA-4D1B-A32E-8CE369572376Q47403876-B8D62075-A7EE-4045-B986-A86FDDD450FBQ47428394-39C43000-3E93-4143-8258-D42EE5063E86Q47859915-9BED5934-4ADF-4929-811A-2C5B70E262B5Q48004049-3295B30E-645E-4F88-8857-E7D4A6B75F04Q49408736-4DF56A41-F21C-4B67-A879-4FAF404E6303Q53776182-A7A13D28-D924-4D27-A931-2BA7282A67B7Q57491423-7E937500-9695-43DC-A49F-EDDF2BC9D233
P2860
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@ast
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@en
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@nl
type
label
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@ast
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@en
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@nl
prefLabel
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@ast
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@en
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@nl
P2093
P2860
P921
P3181
P1433
P1476
The Direct Effects of Fingolim ...... r Relapsing Multiple Sclerosis
@en
P2093
Anthony T. Reder
James D. Bowen
Samuel F. Hunter
P2860
P2888
P304
P3181
P356
10.1007/S40263-015-0297-0
P407
P5008
P577
2016-02-01T00:00:00Z